Tirzepatide 20mg

Two receptors, one mechanism

Tirzepatide activates GLP-1 and GIP receptors simultaneously, placing it among the newest generation of dual incretin agonists. This combination is central to current studies on metabolism and energy balance.

This 20 mg pack in the lab

The 20 mg pack fits experiment series with several repetitions, without needing to reorder in between. The dual mechanism makes Tirzepatide an important tool for studying glucose regulation and energy metabolism.

Example calculation: reconstitution

For a working concentration of 10 mg/ml, the 20 mg vial is reconstituted with 2 ml of sterile solvent (add slowly along the inner wall of the vial, then swirl gently — never shake). Step-by-step process: Application Guide.

Quality you can measure

Each batch is checked by HPLC for ≥98.9% purity, with a certificate of analysis included.

Other sizes: 10 mg 30 mg

Why choose 20 mg instead of 10 mg?

For several repetitions or a longer experiment duration, a larger pack reduces how often you need to reorder.

For research purposes only. Not intended for human consumption.